The example of a newborn baby with Down's syndrome who had a
cystic hygroma in his left arm and forearm is described in the current study.
Cystic hygromas are a type of lymphangioma that commonly develop in the axilla
and cervico-facial regions. The main indications for treatment include
respiratory distress, recurring infections, or aesthetic concerns. On day one
of life, a newborn male neonate with characteristics of Down's syndrome
complained of swelling in his left arm and left forearm to the special care
nursery (SCN) of our institution. OK-432 was used to treat the baby's left arm
edema. However, the patient died at the age of five months from acute sepsis
brought on by the gangrene in his left arm and the accompanying meningitis. For
the past 20 years, the drug picibanil, also known as OK-432, has been used to
effectively treat cystic hygroma. Although nuchal lymphangioma, Turner's
syndrome, and Noonan syndrome have all been linked to cystic hygroma, there is
proof that the condition affects people with Down's syndrome more commonly. In
order to better understand the negative effects of sclerosant therapy, which
has the potential to be the best treatment for cystic hygroma, more case
controlled studies should be carried out in the future.
Author(s) Details:
Chin Aun Low,
Department of Orthopaedic Surgery, Hospital Tuanku Ampuan Najihah,
Kuala Pilah, Malaysia.
Foead Agus Iwan,
Department of Orthopaedic Surgery, Hospital Tuanku Ampuan Najihah,
Kuala Pilah, Malaysia.
Please see the link here: https://stm.bookpi.org/CPMS-V5/article/view/7663
No comments:
Post a Comment